MedPath

The effect of logo therapy on anxiety and coping with unplanned pregnancy: a randomized controlled trial

Not Applicable
Recruiting
Conditions
nplanned pregnancy.
Registration Number
IRCT20231107059988N1
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
52
Inclusion Criteria

Married women aged 18-49 years
Women with an unplanned pregnancy with a decision to continue the pregnancy with a gestational age of 16 to 24 weeks
Ability to communicate
Women whose anxiety score is between 8-19 (mild, moderate, severe anxiety) in the DASS-21 questionnaire

Exclusion Criteria

Cases of fetal abnormalities
Having a high-risk pregnancy including diabetes, high blood pressure, chronic diseases affecting pregnancy such as heart disease, vascular disease, lung disease, etc.
History or current suffering from mental problems or history of hospitalization in a psychiatric hospital (according to the individual's own statement)
Experiencing an unfortunate incident in the last six months, including the death of a loved one

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: At the beginning of the study and 4 weeks after the end of the intervention. Method of measurement: DASS-21 questionnaire.;Coping. Timepoint: At the beginning of the study and 4 weeks after the end of the intervention. Method of measurement: Revised pregnancy coping inventory: NU-PCI.
Secondary Outcome Measures
NameTimeMethod
Health practice. Timepoint: At the beginning of the study and 4 weeks after the end of the intervention. Method of measurement: Health Practices Questionnaire-II: HPQ-II.;Quality of life in pregnancy. Timepoint: At the beginning of the study and 4 weeks after the end of the intervention. Method of measurement: QOL-GRAV: Quality of life-Gravity.
© Copyright 2025. All Rights Reserved by MedPath